ArticleFrontiers in molecular medicine2025
MYC is in the CARDs: CBM complexes coordinate immune and MYC-dependent cellular function.
Article in Frontiers in molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MYC is a transcription factor crucial for a host of cellular functions from proliferation to metabolism, and MYC dysregulation contributes to disease pathogenesis. A growing body of evidence suggests that MYC signaling is regulated by the caspase activation and recruitment domain-coiled-coil (CARD-CC) proteins: a family of immunological signaling mediators that canonically drive NF-κB signaling across nearly all tissues. MYC regulation coordinated by the CARD-CC proteins occurs by multiple mechanisms, including transcription, physical binding, and subcellular localization. Herein, we highlight the hallmark studies that collectively broaden the sphere of influence of CBM complexes beyond NF-κB to include MYC, which has functional impact on cells within and likely beyond the immune system. The studies reviewed herein provide rationale for future studies that examine non-canonical CBM-MYC signaling, its relationship with canonical NF-κB signaling, and its contribution to human health and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.